Identifying cellular signalling molecules in developmental disorders of the brain: Evidence from focal cortical dysplasia and tuberous sclerosis. (9th May 2021)

• Record Type: Journal Article
• Authors: Li, Yao‐Feng; Scerif, Fatma; Picker, Simon R.; Stone, Thomas J.; Pickles, Jessica C.; Moulding, Dale A.; Avery, Aimee; Virasami, Alex; Fairchild, Amy R.; Tisdall, Martin; Harkness, William; Cross, J Helen; Hargrave, Darren; Guillemot, Francois; Paine, Simon M.; Yasin, Shireena A.; Jacques, Thomas S.
• Is Part Of: Neuropathology & applied neurobiology. Volume 47:Number 6(2021)
• Page Start: 781
• Page End: 795
• Publication Date: 2021-05-09
• Subjects: epilepsy -- balloon cells -- focal cortical dysplasia -- tuberous sclerosis -- CHI3L1 -- CCL2 -- molecular profiling -- slice culture; Nervous system -- Diseases -- Pathology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/nan.12715
• Languages: English
• ISSNs: 0305-1846

Abstract

Abstract: Aims: We understand little of the pathogenesis of developmental cortical lesions, because we understand little of the diversity of the cell types that contribute to the diseases or how those cells interact. We tested the hypothesis that cellular diversity and cell–cell interactions play an important role in these disorders by investigating the signalling molecules in the commonest cortical malformations that lead to childhood epilepsy, focal cortical dysplasia (FCD) and tuberous sclerosis (TS). Methods: Transcriptional profiling clustered cases into molecularly distinct groups. Using gene expression data, we identified the secretory signalling molecules in FCD/TS and characterised the cell types expressing these molecules. We developed a functional model using organotypic cultures. Results: We identified 113 up‐regulated secretory molecules in FCDIIB/TS. The top 12 differentially expressed genes (DEGs) were validated by immunohistochemistry. This highlighted two molecules, Chitinase 3‐like protein 1 (CHI3L1) and C‐C motif chemokine ligand 2 (CCL2) (MCP1) that were expressed in a unique population of small cells in close proximity to balloon cells (BC). We then characterised these cells and developed a functional model in organotypic slice cultures. We found that the number of CHI3L1 and CCL2 expressing cells decreased following inhibition of mTOR, the main aberrant signalling pathway in TS and FCD. Conclusions: Our findings highlight previously uncharacterised small cell populations in FCD and TS which express specific signalling molecules. These findings indicate a new level of diversity and cellular interactions in cortical malformations and provide a generalisable approach to understanding cell–cell interactions and cellular heterogeneity in developmental neuropathology. Abstract : We explored the cellular diversity and cell–cell interactions playing a role in the pathology of developmental cortical lesions, specifically FCD and TS lesions. These data indicate a new level of diversity and cellular interactions in cortical malformations and provides a generalisable approach to understanding cell–cell interactions and cellular heterogeneity in developmental neuropathology.